Effect of Yunkang Oral Solution on pregnant mice with spleen deficiency syndrome.
10.19540/j.cnki.cjcmm.20230602.401
- Author:
Chen-Xing WANG
1
;
Mei-Qiu YAN
1
;
Jie SU
1
;
Jing-Jing YU
1
;
Jing-Yan GUO
1
;
Ting LI
1
;
Ya-Juan TIAN
1
;
Zhuang-Wei NIU
1
;
Su-Hong CHEN
2
;
Gui-Yuan LYU
1
Author Information
1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University Hangzhou 310053, China.
2. Zhejiang University of Technology Hangzhou 310014, China.
- Publication Type:Journal Article
- Keywords:
Yunkang Oral Solution;
intestinal barrier;
pregnancy;
pregnancy outcome;
spleen deficiency
- MeSH:
Pregnancy;
Female;
Mice;
Humans;
Animals;
Spleen;
Ghrelin;
Fetal Weight;
Cholesterol, LDL;
Diarrhea
- From:
China Journal of Chinese Materia Medica
2023;48(20):5592-5602
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to investigate the therapeutic effect of Yunkang Oral Solution on the improvement of spleen deficiency and pregnancy outcomes in pregnant mice with spleen deficiency syndrome induced by irregular diet and over consumption of cold and bitter foods. To simulate human irregular diet and over consumption of cold and bitter foods leading to spleen deficiency, the pregnant mice with spleen deficiency syndrome were prepared using an alternate-day fasting and high-fat diet combined with oral administration of Sennae Folium. During the experiment, spleen deficiency-related indicators and diarrhea-related parameters were measured. Gastric and intestinal motility(gastric emptying rate and intestinal propulsion rate) were evaluated. The levels of serum ghrelin, growth hormone(GH), gastrin(Gas), total cholesterol(TC), low-density lipoprotein cholesterol(LDL-c), chorionic gonadotropin β(β-CG), progesterone(P), and estradiol(E_2) were measured. Intestinal barrier function in pregnant mice with spleen deficiency syndrome was assessed. Conception rate, ovarian coefficient, litter-bearing uterine coefficient, number of live fetuses, average fetal weight, and fetal length were calculated. The results showed that Yunkang Oral Solution significantly improved spleen deficiency-related indicators and diarrhea in pregnant mice with spleen deficiency syndrome, increased gastric emptying rate and intestinal propulsion rate, elevated the levels of gastrointestinal hormones(ghrelin, GH, and Gas) in the serum, and reduced lipid levels(TC and LDL-c), thereby improving lipid metabolism disorders. It also improved colonic tissue morphology, increased the number of goblet cells, and promoted the mRNA and protein expression of occludin and claudin-1 in colonic tissues, thereby alleviating intestinal barrier damage. Yunkang Oral Solution also regulated the levels of pregnancy hormones(β-CG, P, and E_2) in the serum of pregnant mice with spleen deficiency syndrome. Moreover, it increased the conception rate, ovarian coefficient, litter-bearing uterine coefficient, number of live fetuses, average fetal weight, and fetal length. These findings suggest that Yunkang Oral Solution can improve spleen deficiency-related symptoms in pregnant mice before and during pregnancy, regulate pregnancy-related hormones, and improve pregnancy outcomes.
